Pharmacologic Manipulation of Fetal Hemoglobin

This publication has 12 references indexed in Scilit:

• Hematologic Responses of Patients with Sickle Cell Disease to Treatment with Hydroxyurea
  New England Journal of Medicine, 1990
• 5-Azacytidine increases HbF production and reduces anemia in sickle cell disease: dose-response analysis of subcutaneous and oral dosage regimens
  Blood, 1985
• The effect of hydroxyurea on hemoglobin F in patients with myeloproliferative syndromes
  Blood, 1985
• Pharmacological Manipulation of Fetal Hemoglobin Synthesis in Patients with Severe β‐Thalassemia
  Annals of the New York Academy of Sciences, 1985
• Augmentation of Fetal-Hemoglobin Production in Anemic Monkeys by Hydroxyurea
  New England Journal of Medicine, 1984
• Treatment of sickle cell anemia with 5-azacytidine results in increased fetal hemoglobin production and is associated with nonrandom hypomethylation of DNA around the gamma-delta-beta-globin gene complex.
  Proceedings of the National Academy of Sciences, 1983
• 5-Azacytidine increases gamma-globin synthesis and reduces the proportion of dense cells in patients with sickle cell anemia
  Blood, 1983
• 5-Azacytidine increases gamma-globin synthesis and reduces the proportion of dense cells in patients with sickle cell anemia
  Blood, 1983
• 5-Azacytidine Selectively Increases γ-Globin Synthesis in a Patient with β⁺Thalassemia
  New England Journal of Medicine, 1982
• 5-Azacytidine stimulates fetal hemoglobin synthesis in anemic baboons.
  Proceedings of the National Academy of Sciences, 1982